Canada is expected to see a rise in new cancer cases and deaths in 2024, but overall case and death rates should continue to fall.
That is according to a new report published Monday in the Canadian Medical Association Journal.
It projects there will be 247,100 cases of cancer and 88,100 deaths throughout the year. Officials said the anticipated increase is largely because of our country’s growing and aging population.
Meanwhile, the overall case and deaths rates are expected to continue their decline this year. The study credits continued efforts and improvements in prevention, screening, and treatment.
Lung, breast, prostate, and colorectal cancer are expected to make up nearly half of all new cases. Lung cancer is anticipated to remain the most deadly, accounting for one-quarter of all cancer deaths.
While the study reported “notable improvements” in lung and colorectal cancer rates, it also highlights “concerning trends” around several other cancers, including liver, kidney, and melanoma.
It said the rise in melanoma is a continued cause for concern given the known relationship with exposure to UV radiation.
The report also noted that while cancer remains the leading cause of death in Canada, more people are surviving longer after their diagnosis.
Estimates in 2022 suggested that more than 1.5 million people in Canada were living with and beyond cancer up to 25 years after diagnosis.
Officials said the growing population of cancer survivors, combined with the projected annual increase in new cancers, will have a substantial impact on Canadian health care systems.
The study’s authors said more investment is needed across all areas of cancer control and care.
Comments